Seegnal's operating subsidiary Seegnal E-Health Ltd. hires AI VP to Strengthen AI Capabilities and Accelerates Development of Seegnal Guard

About this update from Seegnal Inc.

[{"type":"text","content":"\n\n\nSeegnal's operating subsidiary Seegnal E-Health Ltd. hires AI VP to Strengthen AI Capabilities and Accelerates Development of Seegnal Guard\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n\n\n\n\n\nCanada NewsWire\n\n\n/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/\nCALGARY, AB, Jan. 5, 2026 /CNW/ - Seegnal Inc. (TSXV: SEGN), a global leader in clinical decision support solutions applying patient-centric medication safety standards, today announced a major enhancement of its artificial intelligence capabilities with the appointment of Yura Zharkovsky as Vice President of Artificial Intelligence (VP AI) at Seegnal eHealth Ltd., the Company's operating subsidiary in Israel.\nThe appointment, effective January 4, 2026, represents a strategic milestone in Seegnal's mission to build the Intelligence Layer of Prescriptions and to accelerate the development of Seegnal Guard, the Company's next-generation, AI-enhanced, human-led prescription intelligence system.\nAs Seegnal advances toward becoming a global Prescription Intelligence Platform - providing healthcare systems with an infrastructure layer for safer, more consistent, and economically aligned prescribing - Mr. Zharkovsky will lead the technical evolution of the Company's AI stack. His mandate includes expanding Seegnal Guard's predictive and personalization capabilities while preserving Seegnal's core principle: AI that augments, rather than replaces, clinical judgment.\nMr. Zharkovsky brings deep experience in building and scaling applied AI in healthcare. Most recently, he served as Head of AI at NeuroKaire, where he led the development of an AI-supported clinical system designed to assist in selecting appropriate treatments for patients with major depressive disorder. Prior to that, he held senior data science and machine learning leadership roles, focusing on translating complex clinical and biomedical data into deployable, high-reliability AI systems used in real-world care environments.\nKnown for his rigorous engineering standards, strong eth...

More updates from Seegnal Inc.